Risk Factors Update Summary
- Our revenue decreased from $1,655 million in 2022 to $914 million in 2023, a 45% decrease.
- The founder controls the majority of voting power, impacting key decision-making and potentially conflicting with other stockholders' interests.
- The founder's ability to control director elections and exercise voting rights may impact corporate governance.
- The Share Repurchase Program now has an expiration date of December 31, 2024.
- A material weakness in internal control over financial reporting was identified, impacting accurate financial reporting.
- Failure to meet ESG goals could result in legal proceedings and adversely affect business, reputation, and stock price.
- The 2024 Share Repurchase Program may be suspended or discontinued by the Board of Directors.
- The 2022 Revolver includes financial covenants limiting actions, potentially affecting operations and financial results.
- The trading price of Class A common stock may fluctuate due to various factors, including operating performance and economic conditions.
- Repurchases under the 2024 Share Repurchase Program will decrease the number of outstanding shares.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1494259&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.